1. P-086EndoTAG-1 plus gemcitabine versus gemcitabine alone in patients with measurable locally advanced and/or metastatic adenocarcinoma of the pancreas failed on FOLFIRINOX treatment. (2nd July 2019) Authors: Su, M; Chen, L; Hitre, E; Lee, W; Bai, L; Papai, Z; Kang, S; Dvorkin, M; Lee, M; Ludovic, E; Choi, H; Oh, S; Bodoky, G; Artru, P; Hwang, J; Bazin, I; Bosc, F; Bachet, J; Horváth, Z; Chang, C Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗